I know it's peanuts to a lot of you, but I just like to see the line go up
Your request has been blocked due to a network policy. Try logging in or creating an account here to get back to browsing. If you're running a script or application, please register or sign in with your developer credentials here. Additionally make sure your User-Agent is not empty and is…#reddittermsofservice (Source: Reuters: Health)
Source: Reuters: Health - March 23, 2024 Category: Consumer Health News Source Type: news

Ben Shapiro and the conservative myth about Social Security
Conservative broadcaster and gadfly Ben Shapiro stopped by the peanut gallery this week, where he offered thoughts on retirement and Social Security and went 0-for-2.#benshapiro #socialsecurity (Source: Reuters: Health)
Source: Reuters: Health - March 14, 2024 Category: Consumer Health News Source Type: news

Why You Hate Bringing Your Lunch to Work
Jeff Moriarty was once the guy who always brought his lunch to work. Pre-pandemic, he dutifully meal-prepped for the week on Sundays, and when he worked from home during the worst parts of COVID-19, he whipped up healthy feasts between meetings. Grilled chicken salad? Coming right up. Scrambled eggs in the afternoon? “They’re not just for breakfast,” he says. But Moriarty, 44, who lives in Bolingbrook, Ill., and works in e-commerce, hasn’t packed a lunch since going back to the office a year ago. “Lunch has turned into my great escape,” he says. “It’s my daily mini-vacatio...
Source: TIME: Health - March 13, 2024 Category: Consumer Health News Authors: Angela Haupt Tags: Uncategorized Evergreen healthscienceclimate Source Type: news

Hold off on the Egg McMuffins before GES tests, experts say
Nuclear medicine technologists are being advised that not just any meal works for patients before gastric emptying scintigraphy (GES), a common imaging procedure to evaluate how ingested food moves through the stomach. In a recent article published March 1 in the Journal of Nuclear Medicine Technology, Jena-Lee McKee, of Dyersburg Hospital in Tennessee, and Mary Beth Farrell, of the Intersocietal Accreditation Commission in Ellicott City, Maryland, advised technologists that special-order meals will not deliver accurate results and will serve up a “buffet of confusion” and irreproducible results. “Stop squirting Tc...
Source: AuntMinnie.com Headlines - March 7, 2024 Category: Radiology Authors: Will Morton Tags: Subspecialties Nuclear Medicine Radiologic Technologist Nuclear Radiology Source Type: news

How to Use Apps to Actually Make Friends
With loneliness at epidemic levels in the U.S., many people could use a few more friends to lean on. Survey data suggest that many U.S. adults want to make new friends—perhaps because strong relationships are one of the best predictors of happiness and well-being—but struggle to do so. About 8% of U.S. adults say they don’t have any close friends at all. [time-brightcove not-tgx=”true”] Enter the apps. Bumble for Friends, Hey! VINA, Wink, and plenty more promise to help people make friends online. Many work just like dating apps: you build a profile that includes photos and a bio, then swi...
Source: TIME: Health - March 6, 2024 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate Source Type: news

Drug cuts risk of allergic reactions to peanuts and other foods
Researchers showed that a drug used to treat allergic asthma can reduce reactions to peanuts and other common foods in children with multiple food allergies. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - March 5, 2024 Category: Consumer Health News Source Type: news

Peanut Allergen Sensitization Seen in Younger Siblings of LEAP Study Participants
(MedPage Today) -- WASHINGTON -- Among the younger siblings of children who consumed peanut allergens as part of the LEAP trial, there was a trend toward peanut sensitization, though this effect was reduced if peanut was introduced early, results... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - March 1, 2024 Category: Allergy & Immunology Source Type: news

AAAAI: Omalizumab Superior to Placebo for Those With Multiple Food Allergies
MONDAY, Feb. 26, 2024 -- Omalizumab treatment for 16 weeks is superior to placebo for increasing the reaction threshold for peanut and other food allergens among persons with multiple food allergies, according to a study published online Feb. 25 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 26, 2024 Category: Pharmaceuticals Source Type: news

Drug Slashes Risk of Severe Allergic Reactions to Multiple Foods
(MedPage Today) -- WASHINGTON -- Regular courses of omalizumab (Xolair) injections increased the amount of peanut and other foods that multi-food allergic children could consume without an allergic reaction, data from the first stage of the randomized... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - February 26, 2024 Category: Allergy & Immunology Source Type: news

New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies
Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year consumed without an allergic reactionThe U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergiesAllergic reactions can be life-threatening and it is estimated that food-related anaphylaxis results in 30,000 medical events treated in emergency rooms in the U.S. each year1-3Basel, 25 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today data from Stage 1 of the N...
Source: Roche Investor Update - February 25, 2024 Category: Pharmaceuticals Source Type: news

New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies
Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts, egg, milk and wheat that people as young as 1 year consumed without an allergic reactionThe U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergiesAllergic reactions can be life-threatening and it is estimated that food-related anaphylaxis results in 30,000 medical events treated in emergency rooms in the U.S. each year1-3Basel, 25 February 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today data from Stage 1 of the N...
Source: Roche Media News - February 25, 2024 Category: Pharmaceuticals Source Type: news

Omalizumab Increases the Reaction Threshold for Peanut and Other Common Food Allergies
Study highlights a valuable option for safe and effective food allergy treatment. WASHINGTON, Feb. 25, 2024 /PRNewswire-PRWeb/ -- Sixteen weeks of omalizumab results in a higher tolerated threshold for multiple food allergies according to new research presented today at the 2024 American... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - February 25, 2024 Category: Pharmaceuticals Tags: TRI SVY Source Type: news

Xolair for food allergies: How it works and what it costs
Kevin Wang and Annie Marqueling’s son Liam was 8 months old when he broke out in hives all over his body after eating a few bits of a scrambled egg. An allergy test revealed Liam was allergic to eggs, as well as peanuts and tree nuts, and for the next year, the entire family avoided foods that…#kevinwang #anniemarquelings #wang #paloalto #xolair #sharonchinthrajah #stanforduniversity #chinthrajah #fda #annalsofallergy (Source: Reuters: Health)
Source: Reuters: Health - February 25, 2024 Category: Consumer Health News Source Type: news

Drug Drastically Reduces Children ’s Reactions to Traces of Food Allergens
Xolair cuts the risk of dangerous reactions after exposure to minute amounts of allergens, researchers reported. But children taking it still must avoid risky foods. (Source: NYT Health)
Source: NYT Health - February 25, 2024 Category: Consumer Health News Authors: Roni Caryn Rabin Tags: your-feed-science Allergies Food Peanuts Children and Childhood Research Drugs (Pharmaceuticals) Immune System Eggs Milk Clinical Trials American Academy of Allergy Asthma and Immunology New England Journal of Medicine Genentech Source Type: news

An Asthma Drug Can Drastically Reduce Food Allergies
About 20 million people in the U.S.—including four million children—have food allergies. Now, there’s a new way to reduce their risk of severe allergic reactions. A study published in the New England Journal of Medicine reports that the drug omalizumab, or Xolair, allows people with food allergies to tolerate higher doses of allergenic foods before developing a reaction after an accidental exposure. It also leads to milder reactions if they are exposed. [time-brightcove not-tgx=”true”] The drug was originally approved more than two decades ago to treat allergic asthma. But because of this ...
Source: TIME: Health - February 25, 2024 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news